Powered by: Motilal Oswal
2023-11-11 09:40:36 am | Source: Motilal Oswal Financial Services
Buy Indian Oil Corporation Ltd For Target Rs.115 - Motilal Oswal Financial Services
Buy Indian Oil Corporation Ltd For Target Rs.115 - Motilal Oswal Financial Services

Weak petchem offsets marketing and refining gains

* IOCL reported EBITDA of INR213b (up 4.3x YoY), in line with our estimate of INR210b, led by better-than-expected GRM at USD17.9/bbl (vs. our est. of USD14.9/bbl) and higher marketing GM at INR5.8/lit. (vs. our estimate of INR5/lit).

* Refining throughput came in line with our estimate at 17.8mmt (up 10% YoY). In the marketing segment, domestic sales volumes were also in line with our estimate at 21.9mmt (up 2% YoY).

* Singapore GRM has declined to USD3.3/bbl in 3QFY24 to date from USD9.8/bbl in 2QFY24, which may lead to a decline in the refining performance in the coming quarter. A decline in Russia crude discounts may also weigh on IOCL’s performance in the ensuing quarter.

* OMCs are estimated to be generating marketing margin of INR8.2 on petrol and a marketing loss of INR3.8 on diesel in 3QFY24 to date. Margins may also be affected by retail fuel price cuts in the wake of upcoming elections and/or a rise in crude oil prices due to quota management by OPEC+.

* Petchem sales volumes increased by 53% YoY to 0.82mmt (vs. 0.54mmt in 2QFY23). Petchem EBIT came in at INR1.6b (below our est. of INR3.2b). Petchem margins have declined 13%/4% for PE/PP in 3QFY24 to date.

* Owing to a robust performance in 1HFY24, we increase our EBITDA/PAT estimates by 11%/13% for FY24 while keeping FY25 estimates broadly unchanged. The stock trades at 6.9x consolidated FY25E EPS and 0.7x FY25E P/BV. We retain our BUY rating on the stock, valuing it at 0.9x FY25E P/BV.

EBITDA, throughput and domestic sales in line with estimates

* Reported GRM at USD17.9/bbl beat our est. of USD14.9/bbl (USD8.3/bbl in 1QFY24). Refining throughput was in line with est. at 17.8mmt (up 10% YoY).

* Marketing margin (incl. inv.) at INR5.8/lit was above our est. of INR5/lit (INR8.7/lit in 1QFY24). Marketing volumes, excluding exports, were in line with our estimate at 21.9mmt (+2% YoY).

* Petchem EBIT came in at INR1.6b (below our est. of INR3.2b).

* EBITDA came in line with our est. at INR213.1b (up 4.3x YoY).

* PAT came in line at INR129.7b (net loss of INR2.7b in 2QFY23).

* In 1HFY24, EBITDA grew 4.7x YoY to INR435b, with PAT at INR267b (vs. net loss of INR23b in 1HFY23). 1HFY24 EBITDA stands at 71% of our FY24 estimates, while PAT stands at 79% of our FY24 estimates.

* Refining throughput was up 4% YoY at 36.5mmt, with reported GRM at USD13.1/bbl (vs. USD25.5/bbl in 1HFY23). Marketing margin stood at INR7.3/lit (vs. -INR3.9/lit in 1HFY23).

* IOCL had a cumulative negative net buffer of INR2.2b as of 31st Mar’23 due to under recovery on LPG cylinders. The same has been recognized as part of revenue upon recovery in 1HFY24.

* The company has declared an interim dividend of INR5/share in 2Q.

 

For More Motilal Oswal Securities Ltd Disclaimer http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html

SEBI Registration number is INH000000412

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here